MABCURE INC. (MBCI)
MabCure Inc. is a development stage company and engages in developing and commercializing proprietary antibody technology for the early detection of cancer, and for the creation of antibodies and novel drugs against cancer. It owns rights to a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008. MabCure Inc. was founded in 2006 and is based in Hasselt, Belgium.
To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:
|Business Address:||760 Parkside Avenue, Suite 208, Brooklyn, NY 11226, United States|
|State of Inc:||-|